Skip to main content

Table 3 Age-dependent incidence rate ratios of specific cancer types in the FCCTX cohort without the 37 families that fulfilled the criteria for genetic testing for hereditary breast and ovarian cancer or hereditary gastric cancer conpared to the age and sex-matched population-based cohort

From: Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort

  FCCTX subset vs. Population-based cohort
CancerAge groupsIRR95% CI lower95% CI UpperP values
Breast cancer (n = 36)0–290.000.0023.911.0000
30–490.190.020.670.0002*
50–690.800.461.260.2639
70+0.560.191.270.1104
Urothelial cancer (n = 33)0–2910.100.0673.700.0947
30–490.510.003.651.0000
50–690.650.251.360.2011
70+1.530.832.590.0568
Lung cancer (n = 25)0–290.000.0082.681.0000
30–490.970.172.971.0000
50–690.350.150.67< 0.0001*
70+0.320.110.740.0002*
Pancreatic cancer (n = 13)0–290.000.00351.131.0000
30–490.000.005.781.0000
50–690.750.172.080.6967
70+1.270.422.890.4249
Gastric cancer (n = 12)0–290.000.00137.041.0000
30–492.940.3610.510.0840
50–690.380.021.730.2642
70+1.270.393.040.5161
Eye tumours (n = 4)0–290.000.0040.981.0000
30–490.000.0018.101.0000
50–696.191.1119.070.0044*
70+0.000.0015.201.0000
  1. *Significant p values following Bonferoni correction